Who is it for?
RENEW-MDD-1 is a clinical research study for adults with major depressive disorder (MDD) who are taking a treatment that is helping manage their symptoms.
Why?
MDD significantly impacts how an individual feels, thinks and handles daily activities. It is more than just a temporary feeling of sadness; it can lead to severe symptoms that disrupt an individual’s day to day life.
This study will test if the investigational drug, together with the current treatment, is safe and can help people with MDD stay well for longer.
Patients who meet the following criteria may be able to join:
- Aged 18 to 75 years
- Diagnosed and taking treatment for major depressive disorder (MDD)
- Feeling mentally well for up to 6 months (but no longer)
- Body mass index (BMI) of at least 22
To find out more:
You can download the information leaflet here.
If you think that this study could be suitable for you, please contact
email: [email protected] with the Subject RENEW-MDD-1
or telephone 01865 902 135
for more information.
